Literature DB >> 3038233

Biochemical and ultrastructural findings in Epstein-Barr virus-transformed lymphoid cell lines from type 1 Gaucher disease.

A Maret, R Salvayre, N Livni, J Icart, M Vuillaume, L Douste-Blazy.   

Abstract

Lymphoid cell lines established by Epstein-Barr Virus (EBV)-transformation of peripheral blood B-lymphocytes from patients affected with type 1 Gaucher disease showed a severe deficiency of glucosylceramide-beta-glucosidase activity (residual activity around 15%-30% of control activity). Ultrastructural investigations showed, in these lymphoid cell lines from type 1 Gaucher disease, the presence of numerous membrane-bound inclusion bodies characteristic of Gaucher cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038233     DOI: 10.1111/j.1768-322x.1987.tb00519.x

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  4 in total

1.  Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases.

Authors:  A S de Mello; F Provin; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

2.  Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders--enumerative conditions for cryopreservation.

Authors:  A S Mello; M G Burin; K Michellin; M Viapiana; R Giugliani; J C Coelho; M E Bauer
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

3.  LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.

Authors:  A S Mello; M P Goldim; J Mezzalira; C S Garcia; V V Daitx; V V Daitz; C D Castilhos; M S Viegas; O V Vieira; J C Coelho
Journal:  Mol Cell Biochem       Date:  2013-09-26       Impact factor: 3.396

4.  Effect of one year of cryopreservation on the activity of lysosomal hydrolases from EBV-transformed lymphocytes.

Authors:  A S de Mello; F B Mendes; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  J Biomed Biotechnol       Date:  2011-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.